Acute benzodiazepine toxicity exacerbated by concomitant oral olanzapine in a patient with pancreatic cancer

Article Type
Changed
Wed, 05/26/2021 - 13:54
Display Headline
Acute benzodiazepine toxicity exacerbated by concomitant oral olanzapine in a patient with pancreatic cancer
Improvements in antiemetic therapy constitute a major advance in oncology. A recent poll of the oncology community by the American Society of Clinical Oncology ranked it as one of the top 5 advances in cancer in the last 50 years.1 Emetogenicity of chemotherapy is defined by risk of emesis in the patient given no antiemetics; high-risk regimens cause nausea and vomiting in >90% of patients, moderate risk in 30%-90%, and low risk in <30%.

 

Click on the PDF icon at the top of this introduction to read the full article. 
 
Article PDF
Issue
The Journal of Community and Supportive Oncology - 14(4)
Publications
Topics
Page Number
178-179
Legacy Keywords
pancreatic cancer, benzodiazepine, toxicity, olanzapine, antiemetic, nausea, vomiting, fumazenil
Sections
Article PDF
Article PDF
Improvements in antiemetic therapy constitute a major advance in oncology. A recent poll of the oncology community by the American Society of Clinical Oncology ranked it as one of the top 5 advances in cancer in the last 50 years.1 Emetogenicity of chemotherapy is defined by risk of emesis in the patient given no antiemetics; high-risk regimens cause nausea and vomiting in >90% of patients, moderate risk in 30%-90%, and low risk in <30%.

 

Click on the PDF icon at the top of this introduction to read the full article. 
 
Improvements in antiemetic therapy constitute a major advance in oncology. A recent poll of the oncology community by the American Society of Clinical Oncology ranked it as one of the top 5 advances in cancer in the last 50 years.1 Emetogenicity of chemotherapy is defined by risk of emesis in the patient given no antiemetics; high-risk regimens cause nausea and vomiting in >90% of patients, moderate risk in 30%-90%, and low risk in <30%.

 

Click on the PDF icon at the top of this introduction to read the full article. 
 
Issue
The Journal of Community and Supportive Oncology - 14(4)
Issue
The Journal of Community and Supportive Oncology - 14(4)
Page Number
178-179
Page Number
178-179
Publications
Publications
Topics
Article Type
Display Headline
Acute benzodiazepine toxicity exacerbated by concomitant oral olanzapine in a patient with pancreatic cancer
Display Headline
Acute benzodiazepine toxicity exacerbated by concomitant oral olanzapine in a patient with pancreatic cancer
Legacy Keywords
pancreatic cancer, benzodiazepine, toxicity, olanzapine, antiemetic, nausea, vomiting, fumazenil
Legacy Keywords
pancreatic cancer, benzodiazepine, toxicity, olanzapine, antiemetic, nausea, vomiting, fumazenil
Sections
Citation Override
JCSO 2016;14:178-179
Disallow All Ads
Alternative CME
Article PDF Media